The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Great. Thanks, everyone, for joining. My name is Scott Schoenhaus. I am the health care tech equity analyst here at KeyBanc. We're a pleasure to have Ben Taylor, CFO of Recursion for a fireside chat.

TL;DR: Turn messy ideas into polished diagrams with Microsoft Visio 2021 Professional. This lifetime license for Windows is only $12.72 with code MARCH15 until March 29 (MSRP $249.99). Sometimes ideas ...

From market cap to ETF weightings, these visuals show how much the Magnificent 7 shape today’s market. Vikki Velasquez is a researcher and writer who has managed, coordinated, and directed various ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Chart Industries and Flowserve agreed to merge in an all-stock deal worth approximately $19 billion, the companies announced Wednesday. Both stocks were falling after the news. The move brings ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing style ...